Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-20-031435)

Filing Details

Accession Number:: 0000899243-20-031435
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-11-18 16:00:11
Reporting Period:: 2020-11-16

Accepted Time:: 2020-11-18 16:00:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1785173	89Bio Inc.	ETNB	Pharmaceutical Preparations (2834)	831114349

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1792062	Quoc Le-Nguyen	C/O 89Bio, Inc. 142 Sansome Street, 2Nd Floor San Francisco CA 94104	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-11-16	4,548	$3.11	4,548	No	4	M	Direct
Common Stock	Disposition	2020-11-16	4,548	$28.11	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-11-16	4,548	$0.00	4,548	$3.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,938		2029-07-30	No	4	M	Direct

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan.
This option represents a right to purchase a total of 26,486 shares of the Issuer's common stock, one quarter of which vested on July 23, 2020, with the remaining three quarters vesting in equal quarterly installments over the following three years.